Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)

Kobayashi Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	41,172	71,536	96,233	95,024	78,253	75,580
Short-Term Investments	10,494	8,300	8,300	14,022	16,085	14,977
Cash & Short-Term Investments	51,666	79,836	104,533	109,046	94,338	90,557
Cash Growth	-45.89%	-23.63%	-4.14%	15.59%	4.18%	9.43%
Receivables	39,584	52,984	47,853	55,147	52,829	54,773
Inventory	29,414	22,081	17,678	15,107	14,139	15,086
Other Current Assets	6,036	3,430	2,828	2,589	2,919	2,296
Total Current Assets	126,700	158,331	172,892	181,889	164,225	162,712
Property, Plant & Equipment	65,425	47,665	34,778	22,524	20,821	21,180
Long-Term Investments	34,435	36,083	32,123	33,177	38,382	43,792
Goodwill	8,687	9,655	7,147	7,189	7,284	1,582
Other Intangible Assets	10,855	11,959	6,160	5,469	5,510	1,530
Long-Term Deferred Tax Assets	3,107	2,647	1,750	1,489	1,443	2,028
Other Long-Term Assets	2	1	2	1	1	2
Total Assets	250,484	267,473	255,827	252,554	238,366	233,398
Accounts Payable	13,866	17,305	18,056	17,444	15,926	17,112
Accrued Expenses	1,503	2,705	2,553	2,486	2,797	2,368
Short-Term Debt	-	-	-	1	13	19
Current Portion of Leases	371	379	261	169	170	190
Current Income Taxes Payable	14,698	29,884	25,317	25,662	26,756	30,000
Other Current Liabilities	9,197	5,838	5,622	4,941	4,445	3,744
Total Current Liabilities	39,635	56,111	51,809	50,703	50,107	53,433
Long-Term Leases	592	608	531	460	505	682
Long-Term Deferred Tax Liabilities	2,216	2,594	1,310	1,564	1,357	2,779
Other Long-Term Liabilities	2,350	2,405	2,244	2,209	1,855	1,784
Total Liabilities	45,791	62,657	57,928	56,955	55,784	60,741
Common Stock	3,450	3,450	3,450	3,450	3,450	3,450
Additional Paid-In Capital	522	522	522	4,183	4,183	4,183
Retained Earnings	203,518	205,681	194,285	200,534	187,071	173,650
Treasury Stock	-24,767	-24,766	-14,482	-23,706	-19,763	-19,762
Comprehensive Income & Other	21,969	19,929	14,124	11,138	7,641	11,136
Total Common Equity	204,692	204,816	197,899	195,599	182,582	172,657
Minority Interest	1	-	-	-	-	-
Shareholders' Equity	204,693	204,816	197,899	195,599	182,582	172,657
Total Liabilities & Equity	250,484	267,473	255,827	252,554	238,366	233,398
Total Debt	963	987	792	630	688	891
Net Cash (Debt)	50,703	78,849	103,741	108,416	93,650	89,666
Net Cash Growth	-46.41%	-23.99%	-4.31%	15.77%	4.44%	9.72%
Net Cash Per Share	680.44	1039.65	1344.98	1387.72	1198.14	1143.47
Filing Date Shares Outstanding	74.34	74.34	76.13	77.28	78.16	78.16
Total Common Shares Outstanding	74.34	74.34	76.01	77.74	78.16	78.16
Working Capital	87,065	102,220	121,083	131,186	114,118	109,279
Book Value Per Share	2753.50	2755.17	2603.46	2516.20	2335.91	2208.93
Tangible Book Value	185,150	183,202	184,592	182,941	169,788	169,545
Tangible Book Value Per Share	2490.62	2464.42	2428.40	2353.37	2172.23	2169.12

Source: S&P Capital IQ. Standard template. Financial Sources.